Ekso Bionics Holdings, Inc. (EKSO) financial statements (2022 and earlier)

Company profile

Business Address 1414 HARBOUR WAY SOUTH
RICHMOND, CA 94804
State of Incorp. NV
Fiscal Year End December 31
SIC 3569 - General Industrial Machinery and Equipment, Not Elsewhere (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments40,40612,862 7,65527,81316,846
Cash and cash equivalents40,40612,862 7,65527,81316,846
Receivables4,6623,389 3,6602,7601,780
Inventory, net of allowances, customer advances and progress billings2,2421,978 3,3713,0251,556
Inventory2,2421,978 3,3713,0251,556
Other undisclosed current assets485191 2811,339502
Total current assets:47,79518,420 14,96734,93720,684
Noncurrent Assets
Operating lease, right-of-use asset216685 
Property, plant and equipment9911,172 2,3652,2492,435
Intangible assets, net (including goodwill)   1896801,215
Goodwill   189189189
Intangible assets, net (excluding goodwill)    4911,026
Other noncurrent assets164320 13412291
Total noncurrent assets:1,3712,177 2,6883,0513,741
TOTAL ASSETS:49,16620,597 17,65537,98824,425
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,4062,930 6,6975,9235,435
Accounts payable3,1071,501 3,1562,4201,879
Accrued liabilities2,2991,429 3,5413,5033,556
Deferred revenue1,2201,496 
Debt     54
Deferred revenue and credits1,103825
Other undisclosed current liabilities229548 3,4352,139 
Total current liabilities:6,8554,974 10,1329,1656,314
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,9932,222 2,6484,830156
Long-term debt, excluding current maturities1,9931,989 2,6484,8306,789
Capital lease obligations  90
Operating lease, liability 233 
Other undisclosed long-term debt and lease obligation     (6,723)
Liabilities, other than long-term debt1,5491,844 1,5629151,129
Deferred revenue and credits816805
Deferred revenue1,4751,806 
Contract with customer, liability1,495
Other liabilities7438 6757107
Business combination, contingent consideration, liability    42217
Other undisclosed noncurrent liabilities1,5507,123 5851,68710,295
Total noncurrent liabilities:5,09211,189 4,7957,43211,580
Total liabilities:11,94716,163 14,92716,59717,894
Stockholders' equity
Stockholders' equity attributable to parent37,2194,434 2,72821,3916,531
Common stock138 636022
Additional paid in capital246,090204,376 173,903165,825121,291
Accumulated other comprehensive income (loss)(17)(847) (92)(340)79
Accumulated deficit(208,867)(199,103) (171,146)(144,154)(114,861)
Total stockholders' equity:37,2194,434 2,72821,3916,531
TOTAL LIABILITIES AND EQUITY:49,16620,597 17,65537,98824,425

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues11,2468,882 11,3327,35314,221
Revenue, net7,35314,221
Cost of revenue
(Cost of Goods and Services Sold)
(4,497)(3,812) (7,023)(5,284)(11,274)
Gross profit:6,7495,070 4,3092,0692,947
Operating expenses(20,577)(18,361) (31,339)(33,681)(30,533)
Operating loss:(13,828)(13,291) (27,030)(31,612)(27,586)
Nonoperating income (expense)4,064(2,534) 382,490(166)
Other nonoperating income (expense)(884)990 (425)2964,116
Interest and debt expense1,099(139) (600)(648)(16)
Other undisclosed income from continuing operations before equity method investments, income taxes 139 6006484,298
Loss from continuing operations before equity method investments, income taxes:(8,665)(15,825) (26,992)(29,122)(23,470)
Loss from equity method investments (66)    
Other undisclosed loss from continuing operations before income taxes(1,099)     
Net loss:(9,764)(15,891) (26,992)(29,122)(23,470)
Other undisclosed net income attributable to parent 66    
Net loss attributable to parent:(9,764)(15,825) (26,992)(29,122)(23,470)
Other undisclosed net loss available to common stockholders, basic     (10,345)
Net loss available to common stockholders, basic:(9,764)(15,825) (26,992)(29,122)(33,815)
Dilutive securities, effect on basic earnings per share     (4,286)
Other undisclosed net loss available to common stockholders, diluted(1,029)     
Net loss available to common stockholders, diluted:(10,793)(15,825) (26,992)(29,122)(38,101)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(9,764)(15,891) (26,992)(29,122)(23,470)
Comprehensive loss:(9,764)(15,891) (26,992)(29,122)(23,470)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent830(831) 248(419)(10,265)
Comprehensive loss, net of tax, attributable to parent:(8,934)(16,722) (26,744)(29,541)(33,735)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: